Healthcare -
Biotechnology - NASDAQ - US
$ 10.14
-2.12 %
$ 764 M
Market Cap
-3.34
P/E
REPL - NET CHANGE IN CASH
Net Change in Cash REPL - Replimune Group, Inc.
-72.1 M
LAST VALUE
2.98%
2 YEAR CAGR
-54.52%
5 YEAR CAGR
0.00%
10 YEAR CAGR